Pulmonary Critical Care & Sleep Medicine is categorized under Health Services in Utica, NY and active since 2012.
Pulmonary Critical Care & Sleep Medicine was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Anwar Wassel at the company’s single location by writing to 50 Prospect St, Utica, New York NY 13501 or by phoning (315) 792-9192. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pulmonary Critical Care & Sleep Medicine |
| Contact Person: | Anwar Wassel |
| Address: | 50 Prospect St, Utica, New York 13501 |
| Phone Number: | (315) 792-9192 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Pulmonary Critical Care & Sleep Medicine was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Anwar Wassel for inquiries that concern Pulmonary Critical Care & Sleep Medicine by calling the company number (315) 792-9192, as your correspondence is most welcome. Additionally, the physical location of the single location of Pulmonary Critical Care & Sleep Medicine can be found at the coordinates 43.082372,-75.26069 as well as the street address 50 Prospect St in Utica, New York 13501.
For its online presence, you may visit Pulmonary Critical Care & Sleep Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.